Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).
Naito Y, Aburatani H, Amano T, Baba E, Furukawa T, Hayashida T, Hiyama E, Ikeda S, Kanai M, Kato M, Kinoshita I, Kiyota N, Kohno T, Kohsaka S, Komine K, Matsumura I, Miura Y, Nakamura Y, Natsume A, Nishio K, Oda K, Oda N, Okita N, Oseto K, Sunami K, Takahashi H, Takeda M, Tashiro S, Toyooka S, Ueno H, Yachida S, Yoshino T, Tsuchihara K; Japanese Society of Medical Oncology; Japan Society of Clinical Oncology; Japanese Cancer Association. Naito Y, et al. Among authors: hayashida t. Int J Clin Oncol. 2021 Feb;26(2):233-283. doi: 10.1007/s10147-020-01831-6. Epub 2020 Nov 29. Int J Clin Oncol. 2021. PMID: 33249514 Free PMC article.
Biological markers of invasive breast cancer.
Matsumoto A, Jinno H, Ando T, Fujii T, Nakamura T, Saito J, Takahashi M, Hayashida T, Kitagawa Y. Matsumoto A, et al. Among authors: hayashida t. Jpn J Clin Oncol. 2016 Feb;46(2):99-105. doi: 10.1093/jjco/hyv153. Epub 2015 Oct 20. Jpn J Clin Oncol. 2016. PMID: 26486826 Review.
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status.
Nakamura K, Aimono E, Oba J, Hayashi H, Tanishima S, Hayashida T, Chiyoda T, Kosaka T, Hishida T, Kawakubo H, Kitago M, Okabayashi K, Funakoshi T, Okita H, Ikeda S, Takaishi H, Nishihara H. Nakamura K, et al. Among authors: hayashida t. Med Oncol. 2021 Mar 12;38(4):36. doi: 10.1007/s12032-021-01482-1. Med Oncol. 2021. PMID: 33710417 Free PMC article.
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA.
Sunami K, Bando H, Yatabe Y, Naito Y, Takahashi H, Tsuchihara K, Toyooka S, Mimori K, Kohsaka S, Uetake H, Kinoshita I, Komine K, Takeda M, Hayashida T, Tamura K, Nishio K, Yamamoto N; Working Group of a Joint Task Force of Three Academic Societies for the Promotion of Cancer Genomic Medicine. Sunami K, et al. Among authors: hayashida t. Cancer Sci. 2021 Sep;112(9):3911-3917. doi: 10.1111/cas.15022. Epub 2021 Jul 12. Cancer Sci. 2021. PMID: 34128569 Free PMC article.
[HOXB9 as a novel prognostic factor in breast cancer].
Seki H, Hayashida T, Jinno H, Takahashi M, Kitagawa Y. Seki H, et al. Among authors: hayashida t. Nihon Rinsho. 2012 Sep;70 Suppl 7:166-9. Nihon Rinsho. 2012. PMID: 23350386 Japanese. No abstract available.
Experimental and clinicopathological analysis of HOXB9 in gastric cancer.
Kato F, Wada N, Hayashida T, Fukuda K, Nakamura R, Takahashi T, Kawakubo H, Takeuchi H, Kitagawa Y. Kato F, et al. Among authors: hayashida t. Oncol Lett. 2019 Mar;17(3):3097-3102. doi: 10.3892/ol.2019.10008. Epub 2019 Feb 4. Oncol Lett. 2019. PMID: 30867739 Free PMC article.
408 results